1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsNIAID conducts and supports research to find new and improved ways to diagnose, treat, and prevent Ebola and Marburg infections.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Investigators at academic institutions, non-profit organizations, and for-profit companies. International institutions are eligible to apply. Confirm the full requirements in the official notice before applying.
The current listing shows varies (e.g., R01 budgets are not limited but need to reflect the actual needs of the proposed project; R21 typically supports up to $275,000 direct costs over two years). Verify award ceilings, matching requirements, and allowable costs in the official notice.
NIAID Investigator-Initiated Research Grants (e.g., R01, R21) is funded by National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Past winners and funding trends for this program
National Institute of Allergy and Infectious Diseases (NIAID) Resource-Related Research Projects (R24 Clinical Trial Not Allowed) is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). This grant supports resource development projects to advance infectious disease and immunology research. It focuses on developing and enhancing resources that facilitate research in these critical areas.
National Institute of Allergy and Infectious Diseases (NIAID) Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). This funding opportunity supports investigator-initiated clinical trials requiring enhanced oversight, with durations up to 7 years. While focused on clinical trials, modeling can be a critical component of trial design and analysis in infectious diseases and immunology.
The memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articlePAR-27-062 creates a three-year, $80,000-salary postdoctoral career award across NCI, NIAID, NIBIB, NIDCR and NINDS — and it carries a hard eligibility window that closes two years after you start your postdoc. Full analysis of the Academic Career Excellence Award, what it replaces, and why the timing rule is the whole competition.
Read articlePA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read article